Casi Pharmaceuticals Inc (CASI)
1.85 x 1 3.00 x 10
Post-market by (Cboe BZX)
2.30 unch (unch) 03/20/25 [NASDAQ]
1.85 x 1 3.00 x 10
Post-market 1.91 -0.39 (-16.96%) 14:31 ET
for Thu, Mar 20th, 2025
Fiscal Year End Date: 12/31
12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
Cash Flows From Operating Activities | |||||
Net Income | -23,862 | -22,411 | -49,889 | -16,313 | -12,622 |
Depreciation Amortization | -254 | -779 | -571 | 82 | 758 |
Accounts receivable | 21 | -57 | -72 | -473 | 178 |
Accounts payable and accrued liabilities | -1,055 | -1,396 | 156 | 3,965 | -2,249 |
Other Working Capital | -57 | -1,851 | -1,399 | 1,644 | -1,089 |
Other Operating Activity | 4,493 | 2,970 | 31,001 | -3,422 | -1,399 |
Operating Cash Flow | $-20,713 | $-23,524 | $-20,775 | $-14,518 | $-16,422 |
Cash Flows From Investing Activities | |||||
Change In Deposits | 10,973 | 12,664 | -9,866 | -4,167 | -11,969 |
PPE Investments | -134 | -107 | -175 | -238 | 192 |
Net Acquisitions | N/A | N/A | -2,906 | N/A | N/A |
Sale Of Investment | N/A | N/A | N/A | N/A | 520 |
Investing Cash Flow | $10,839 | $12,558 | $-12,947 | $-4,405 | $-11,257 |
Cash Flows From Financing Activities | |||||
Debt Issued | N/A | 19,900 | N/A | N/A | N/A |
Debt Repayment | -2,981 | -751 | -697 | N/A | N/A |
Common Stock Issued | N/A | 750 | 43,907 | 9,905 | 13,293 |
Other Financing Activity | -77 | -153 | 0 | 0 | 0 |
Financing Cash Flow | $-3,058 | $19,746 | $43,210 | $9,905 | $13,293 |
Beginning Cash Position | 29,676 | 20,896 | 11,408 | 20,426 | 34,812 |
End Cash Position | 16,743 | 29,676 | 20,896 | 11,408 | 20,426 |
Net Cash Flow | $-12,933 | $8,780 | $9,489 | $-9,018 | $-14,386 |
Free Cash Flow | |||||
Operating Cash Flow | -20,713 | -23,524 | -20,775 | -14,518 | -16,422 |
Capital Expenditure | -134 | -107 | -227 | -249 | -164 |
Free Cash Flow | -20,848 | -23,631 | -21,002 | -14,767 | -16,585 |